NovaBridge Biosciences (NBP) Long-Term Debt Repayments (2019 - 2020)
NovaBridge Biosciences (NBP) posted Long-Term Debt Repayments of $15.1 million for Q4 2020, down 33.53% on a QoQ basis from $22.7 million in Q4 2019, and down 33.53% YoY from $22.7 million in Q1 2020.
NovaBridge Biosciences (NBP) Long-Term Debt Repayments (2019 - 2020) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Long-Term Debt Repayments for 2 consecutive years, with $15.1 million the latest figure, recorded in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -21,671.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | NovaBridge Biosciences | 330.39 Mn | 119.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 15.09 Mn |
| Dec 31, 2020 | 15.09 Mn |
| Dec 31, 2019 | 22.70 Mn |
| Dec 31, 2019 | 22.70 Mn |